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Abstract
Background: There is a growing interest in assessment of the quality of hospital care, based on outcome
measures. Many quality of care comparisons rely on binary outcomes, for example mortality rates. Due to low
numbers, the observed differences in outcome are partly subject to chance. We aimed to quantify the gain in
efficiency by ordinal instead of binary outcome analyses for hospital comparisons. We analyzed patients with
traumatic brain injury (TBI) and stroke as examples.
Methods: We sampled patients from two trials. We simulated ordinal and dichotomous outcomes based on the
modified Rankin Scale (stroke) and Glasgow Outcome Scale (TBI) in scenarios with and without true differences
between hospitals in outcome. The potential efficiency gain of ordinal outcomes, analyzed with ordinal logistic
regression, compared to dichotomous outcomes, analyzed with binary logistic regression was expressed as the
possible reduction in sample size while keeping the same statistical power to detect outliers.
Results: In the IMPACT study (9578 patients in 265 hospitals, mean number of patients per hospital = 36), the
analysis of the ordinal scale rather than the dichotomized scale (‘unfavorable outcome’), allowed for up to 32% less
patients in the analysis without a loss of power. In the PRACTISE trial (1657 patients in 12 hospitals, mean number
of patients per hospital = 138), ordinal analysis allowed for 13% less patients. Compared to mortality, ordinal
outcome analyses allowed for up to 37 to 63% less patients.
Conclusions: Ordinal analyses provide the statistical power of substantially larger studies which have been
analyzed with dichotomization of endpoints. We advise to exploit ordinal outcome measures for hospital
comparisons, in order to increase efficiency in quality of care measurements.
Trial registration: We do not report the results of a health care intervention.
Keywords: Between-hospital variation, Observational data, Comparative effectiveness research, Statistical power,
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Background
There is an ever-growing demand for information on
performance of hospitals to improve quality of care [1].
Clinical outcomes are commonly used to determine
which hospitals are allegedly performing better or worse,
and which are to be labelled as potential outliers [2, 3].
However, comparing outcomes between hospitals has its
limitations. The observed differences in outcome be-
tween hospitals are often partly due to chance [4] and
are only partly explained by actual differences in the
quality of care [5]. Lack of power to detect differences
between hospitals is a common problem for several clin-
ically relevant outcome indicators. For example, compli-
cation rates are generally low and the small number of
events leads to underpowered statistical analyses [6, 7].
Furthermore one of the most commonly used clinical
measures is the (standardized) mortality ratio (SMR)
[8, 9], which has a variety of disadvantages and meth-
odological issues when used as a quality of care
measure [10–12]. The main issue being that mortality
is an especially rare outcome in many patient groups,
leading to low power when trying to detect hospitals
with aberrant outcomes [13].
Many clinical continuous or ordinal outcome scales
do exist and are recorded, but these are often dichot-
omized (favorable and unfavorable) in quality of care
comparisons, for reasons of simplicity. Examples of
ordinal outcome measures are the modified Rankin
Scale (for stroke), the Glasgow Outcome Scale (for
Traumatic Brain Injury (TBI), the Guillain Barré
syndrome disability score, the NYHA Functional
Classification (for heart failure) and the Rutherford
Classification (for peripheral artery disease). Dichoto-
mization has been shown to lead to a loss of clinically
and statistically relevant information in several studies
[14–17] while analysis on the full ordinal scale with
proportional odds analysis, prevents this loss of infor-
mation [18, 19]. Simulation studies and empirical val-
idation studies in clinical trials have demonstrated that
ordinal analysis increases statistical power compared to
binary outcome analysis [18–21]. For clinical trials it has
already been advised not to dichotomize ordinal outcome
scale but to exploit the full ordinal nature of the scale, to
allow for detection of smaller treatment effects [15, 19].
However, this potential gain in efficiency has not been
assessed for hospital comparisons.
Our aim, therefore, is to quantify the gain in power, or
reduction in sample size, that can be achieved by using
ordinal compared to dichotomous outcomes as a meas-
ure of quality of care for hospital comparisons.
Methods
Simulation studies were performed with patients
sampled from two databases. The databases consisted
of hospital data of patients with either TBI in the
International Mission on Prognosis And Clinical
Trial Design in Traumatic Brain Injury (IMPACT)
study [22], and stroke patients in the PRomoting
ACute Thrombolysis in Ischemic StrokE (PRACTISE)
trial [23].
The IMPACT study was a project was organized as a
collaborative venture between the Erasmus University in
Rotterdam, The Netherlands, the University of Edin-
burgh, Scotland, and the Virginia Commonwealth Uni-
versity Medical College in Richmond, Virginia in order
to collect data from available randomized controlled tri-
als (RCTs) and observational studies in TBI conducted
between 1984 and 2007. Although inclusion criteria dif-
fered for the different RCTs data extraction was guided
by a data dictionary to standardize the format of vari-
ables entered into data set, to guarantee the quality of
the data.
The PRACTISE study is a national cluster-
randomised-controlled trial. All patients > 18 years
with acute stroke who were admitted to the hospital
within 24 h from onset of symptoms were included in
the trial. Patients admitted within 4 h were assessed
in detail and were followed up to 3 months after on-
set by telephone. Twelve hospitals participating hospi-
tals were assigned to the regular or high-intensity
intervention.
We sampled patients from the original data sets
and the patients were appointed to one of the 250
fictitious hospitals. The simulations included two sce-
narios, one in which the hospital influenced the out-
come of the patient (A) and one in which outcome of
the patient was completely independent of the hos-
pital (B). In the first scenario (A) hospitals were given
a “center effect”; a coefficient for the effect of hospital
on outcome drawn from a normal distribution with
m = 0 and SD = 0.35. The true outcomes of the hospi-
tals all differed from 0, as can be seen in Fig. 1a. This
meant that patients from one hospital had a higher
chance of a good outcome than those of another [20],
i.e. that ‘true’ hospital differences in outcome existed.
Analysis of scenario A was done to determine the
sensitivity (type II error) which could be achieved
using either ordinal outcomes or dichotomized out-
comes. Since all hospitals were assigned a center ef-
fect, the analysis which found the most hospitals with
performances deviating from the mean had the best
sensitivity for an effect.
In scenario B specificity was tested (Fig. 1b) by check-
ing if the analyses did not find more than 5% of differ-
ently performing hospitals when there was no true
difference in hospital performance.
To simulate outcomes, a multinomial generalized logit
regression model was fitted to predict the probability for
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outcomes for each patient based on the given baseline
covariates. Furthermore, in scenario A the probability
for outcome was either increased or decreased depend-
ing on the hospital the patient was in.
For the baseline covariates of the TBI patients well know
prognostics baseline characteristics were used: Glasgow
Coma Scale (GCS) motor score, age and pupillary reactiv-
ity (both pupils reactive, one pupil reactive, no pupil re-
activity) [22]. In the stroke data the following covariates
were used: baseline National Institute of Health Stroke
Scale (NIHSS) score, age, history of ischemic stroke, atrial
fibrillation, an diabetes mellitus [23].
In TBI, we used the 5-point ordinal Glasgow Out-
come Scale (GOS) at 6-months as an outcome measure
(Fig. 2a). For stroke, we used the modified Rankin Scale
(mRS) at 3 months, a 7-point ordinal scale (Fig. 2b).
These are the most commonly used outcome measures
for these conditions. In both scales, the worst disability
state and death were combined for ethical reasons,
resulting in a 4-point outcome scale for TBI, and a 6-
point outcome scale for stroke [19, 23, 24]. Both or-
dinal outcome measures were thereafter dichotomized,
into favorable (good recovery or moderate disability)
and unfavorable outcome (severe disability, vegetative
state and death) as well as dichotomized for mortality
(including severe disability). Dichotomization for mortal-
ity was done to illustrate the case in which only mortal-
ity rates are measured.
To demonstrate the differences in sensitivity to detect
hospital outliers the simulation was repeated with differ-
ent number of patients per hospital, ranging from 25 to
200, which were distributed over 250 hospitals. Simula-
tions were run 500 times.
Analysis
Outcomes were analyzed on (1) an ordinal scale, (2)
dichotomized as favorable vs. unfavorable outcomes,
and (3) dichotomization for death vs. alive. The bin-
ary outcomes were analyzed with standard fixed effect
logistic regression models, the ordinal outcomes were
analyzed with proportional odds fixed effect logistic
regression models [25, 26]. All models were adjusted
for previously mentioned baseline covariates based on
which the outcomes had been predicted, and included
hospital as a categorical variable. This yielded an esti-
mated center effect per hospital compared to mean
center effects. Hospitals with predicted center effect
values outside the 95% confidence intervals (CIs) of
the overall mean were scored as outliers.
The ability of the model to determine which hospi-
tals were outliers was measured by counting how
many outliers the analysis would find in different sce-
narios. This means that in scenario A, the analysis
which found the most outliers was determined as the
most sensitive, and in scenario B the analyses were
meant to have less than 5% outliers.
Higher power in the analyses results in higher rate
of correctly identified outliers. Therefore, we could
translate the ability to find outliers to the possibility
of sample size reduction. The ability of regression
models to determine which hospitals had aberrant
outcomes, given dichotomized and ordinal outcomes
Fig. 1 Illustration of the data generation process for testing specificity and sensitivity: (a) when a center effect is added (β), resulting in every
hospital performing to different degrees, better or worse than the mean (b) without a hospital effect added (β = 0) all hospitals perform the same
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was expressed in potential efficiency gains. The differ-
ence between ordinal and dichotomized outcomes was
expressed as potential efficiency gain: the possible re-
duction in sample size while keeping the same statis-
tical power to detect outliers. All analyses were done
using R Statistical Software 3.3.0. The script can be
found in Appendix [27–33].
Results
The IMPACT study included data from eight random-
ized controlled trials and three observational studies
[22]. Data from 9578 patients was used, which came
from 265 different centers, which admitted between 1
and 453 patients, which were mostly (78%) male, and
had a median age of 30 (interquartile range (IQR): 21–
45) (Table 1).
The PRACTISE trial was a cluster randomized trial of
studying the implementation of IV thrombolytic
treatment in the Netherlands. It included observational
data of 1657 patients in 12 centers [23]. Hospitals had a
minimum of 28 and maximum of 310 patients, who had
a median age of 73 (IQR: 62–80) (Table 2).
In the IMPACT study 4949 (52%) of the patients had a
favorable outcome and 4629 (48%) had an unfavorable
outcome. Of these, 3031 (32%) were in vegetative state
or died (Fig. 2). In the PRACTISE trial 933 (56%) of the
patients had a favorable outcome and 724 (44%) had an
unfavorable outcome. Of these, 351 (21%) were in se-
verely disabled state or died.
Sensitivity
More patients per hospital increased the percentage
of hospitals which are correctly found to be deviant
from the mean (Fig. 3). Further, use of ordinal out-
comes instead of dichotomized for favorable versus
unfavorable outcome allowed for less patients in the
Fig. 2 Distributions of the Glasgow Outcome Scale (a) and the modified Rankin scale (b), with the vertical line 1 illustrating the point of
dichotomization at the clinically relevant outcome, and line 2 illustrating the point of dichotomization for mortality
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analysis without loss of power; the use of ordinal out-
comes compared to dichotomized outcomes allowed
for up to 13% less patients in the analysis without a
loss of power in the IMPACT study (Fig. 3a) and for
up to 32% less patients in the PRACTISE trial (Fig.
3b). For example, a mean of 73 patients per hospital
was needed to detect the same percentage deviant
hospitals when ordinal outcomes were used compared
to on average 134 patients per hospital when the di-
chotomization favorable versus unfavorable was used
in the PRACTISE trial. Moreover, dichotomization for
mortality required even more patients in the analysis
compared to dichotomization for favorable versus un-
favorable outcome, in this example 200 patients per
hospital. This meant that the required number of
patients could be reduced by 63% for the PRACTISE
trial and up to 37% for the IMPACT study. The
variation across simulations was relatively small
(Appendix Figure 4).
Specificity
To determine specificity, the simulations were per-
formed without simulating true center effects. For all
analyses an increase in sensitivity was not associated
Table 1 Baseline characteristics of patients enrolled in the IMPACT study
n = 9578
Age (median, IQR) 30 (21–45)
Sex
Male (N, %) 7446 (78%)
Pupillary reactivity
Reactive to light (N, %) 7664 (80%)
Not reactive to light (N, %) 1914 (20%)
Motor score
Makes no movements (N, %) 1490 (16%)
Extension to painful stimuli (N, %) 1166 (12%)
Abnormal flexion to painful stimuli (N, %) 1244 (13%)
Flexion / Withdrawal to painful stimuli (N, %) 2208 (23%)
Localizes to painful stimuli (N, %) 2593 (27%)
Obeys commands (N, %) 291 (3%)
Table 2 Baseline characteristics of patients enrolled in the PRACTICE trial
n = 1657
Age (median, IQR) 73 (62–80)
Sex
Male (N, %) 902 (54%)
Atrial fibrillation
Present (N, %) 296 (18%)
Not present (N, %) 1361 (82%)
Diabetes mellitus
Present (N, %) 274 (17%)
Not present (N, %) 1383 (84%)
History of ischemic stroke
Present (N, %) 331 (20%)
Not present (N, %) 1326 (80%)
NIHSSa(mean) 8
aNIHSS indicates National Institutes of Health Stroke Scale; indicator of Stroke severity
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with a decrease in specificity: the type I error did not dif-
fer between analytical approached and was in all cases
below 1%.
Discussion
This study aimed to assess how much power could
be gained by using ordinal analysis instead of dichot-
omous analysis to detect between center differences
in outcome. Use of ordinal outcomes in both stroke
and TBI hospital comparisons, increased statistical
efficiency of the estimation of differences between
centers. The increase in statistical power resulted in
a substantial reduction in required sample size when
using ordinal instead of dichotomous outcomes. This
sensitivity increase came without loss of specificity.
Our results are in line with previous studies on es-
timating treatment effects in RCTs [34–36]. Previous
studies on ordinal outcome analysis in trials, showed
an increase in power, and higher potential of detect-
ing treatment effects [15, 19, 20, 37], with sample size
reductions up to 40%. The current study shows the
use of ordinal data is not only of added value in
RCTs that assess treatment effects, but also in obser-
vational data to assess differences between centers in
outcome. It illustrates to what extent sample size can
be reduced without loss of power compared to the
use of a dichotomous outcome. In the example data-
bases on stroke and TBI, a reduction in sample size
of 37 and 63% was achieved. The difference in power
gain between the two examples could be partly
Fig. 3 Results of the simulation based on the IMPACT database (a) and results of the simulation based on the PRACTICE trial (b). The graph
shows mean number of patients which need to be included per hospital in order to be able to find the number better or worse performing
hospitals, set out for data which has been dichotomized, dichotomized for mortality/severe disability, and which was analyzed respectively on the
full ordinal GOS scale (a), the modified Rankin scale (b)
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explained by the fact that the mRS is used as a 6-
point ordinal scale (originally 7) while the GOS is
used as a 4-point ordinal scale (originally 5). An or-
dinal scale with a higher number of levels may con-
tain more information, and may provide more
discriminability. In addition, the efficiency gain of an
ordinal outcome is optimal if the proportional odds
assumption perfectly holds [38, 39].
In our analysis we used odds based on the true data
from the IMPACT study and PRACTICE trial, in
which the proportional odds assumption is not per-
fectly met. It has however been shown that even if
proportional odds assumptions are violated, analysis
of the ordinal scale is still beneficial over dichotomi-
zation and results are robust regardless of the viola-
tion [20, 40, 41]. In the past the importance of
assumption of proportionality might have been
stressed too much. More important than the propor-
tional odds assumption is the ordering of the adjacent
outcomes. If there is agreement among stakeholders
that each score on a certain scale is more favorable
than a one point lower score, testing for proportional
odds assumptions can be considered redundant [41].
If not, a potential solution is to combine adjacent cat-
egories of the scale that are not perceived ordinal,
e.g. dead and vegetative state.
This study illustrates how much information is lost,
not only by discarding the ordinal outcomes but when
dichotomization leads to low event rates. This is the case
when only mortality ratios are considered, and especially
when mortality at a fixed time point is used. Compared
to ordinal outcomes mortality as outcome requires
much larger sample sizes, in order to find potential dif-
ferences in quality of care.
Using ordinal outcomes, when available, instead of di-
chotomous outcomes to compare hospitals is therefore
strongly recommended. For stroke and TBI this is easily
done, as most centers will be familiar with the use of
these scales in research projects and clinical practice.
We do however recognize that several medical condi-
tions or fields do not have a relevant ordinal outcome
scales. Ideally relevant ordinal scales for important
conditions should be developed or refurbished and
implemented.
The benefits of the use of ordinal scales have also been
shown to have their limits. The chance of misclassifica-
tion, even by extensively trained medical staff, is higher
with the use of ordinal scales. This phenomenon is
represented as the inter-rater reliability [42]. Misclassifi-
cation has been included in the simulation, if misclassifi-
cation is however larger than expected it can possibly
lead to an underestimation of the error rates and an
overestimation of the statistical power of the ordinal
analyses [42–46]. Furthermore, in our analysis we
collapsed vegetative state and mortality for the GOS,
and similarly we collapsed mRS 5 (severe disability) with
mRS 6 (death) into one state. For the GOS it is more of
a common practice since it is questionable whether
vegetative state is a better outcome than mortality. This
has also been done for mRS, although patients in mRS 5
are awake and aware, and on average this is clearly a
preferred health status over death. Clinically this might
be a debatable choice, it is however done on occasion
and in our analysis it makes comparison to the GOS eas-
ier and yields a more conservative estimate of the gain
in power [23, 24].
Dichotomization was done on the collapsed scale
which adds possible misclassification to the dichoto-
mized outcome scale, while true mortality ratios
would not have any misclassification. At the same
time including vegetative state and severe disability
cases increases incidence rates and therefore the
power of the analysis.
In this paper we repeatedly refer to reduction in
sample size using ordinal instead of dichotomous out-
comes. However, since statistical power is a major
challenge in hospital comparisons, we would like to
stress that by this we point out efficiency gain by
using ordinal outcome analysis. Most (studies on)
hospital comparisons are underpowered, and thus we
do not advise aiming for smaller sample sizes when
using ordinal outcomes. In this paper only one aspect
in performing hospital comparisons is addressed. In
general, to be able to perform valid and efficient hos-
pital comparisons one should focus on 1) using larger
sample sizes [47], 2) use ordinal outcome analyses
and 3) sufficient case-mix adjustment.
Strengths and limitations
The advantage of performing simulations on quality of
care data is that we have a priori knowledge of which
hospitals deviate from the mean. A limitation of basing
the simulation on real datasets is that it limits the variety
of situations which are simulated. Furthermore, the
number of patients per hospital was constant in our
study, instead of a mix of smaller and larger hospitals as
one would see in reality.
Conclusion
Use of the ordinal outcomes instead of the binary
outcomes for hospital comparisons, results in consid-
erable efficiency gains. In quality of care research,
where lack of power is a substantial problem, using
ordinal clinical outcomes could be a way to increase
possibilities to find outliers when comparing hospitals.
In cases where an ordinal scale is available we
strongly advise to exploit the ordinal scale and to not
dichotomize in any way.
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Appendix
Fig. 4 Results of the simulation based on the IMPACT database (a) and results of the simulation based on the PRACTICE trial (b). The graph
shows the variability in number of patients which need to be included per hospital in order to be able to find the number better or worse
performing hospitals, set out for data which has been dichotomized, dichotomized for mortality/severe disability, and which was analyzed
respectively on the full ordinal GOS scale (a), the modified Rankin scale(b)
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TBI: Traumatic brain injury; SMR: Standardized mortality ratio; IMPA
CT: International Mission on Prognosis And Clinical Trial Design in Traumatic
Brain Injury; PRACTISE: PRomoting ACute Thrombolysis in Ischemic StrokE;
GCS: Glasgow Coma Scale; mRS: Modified Rankin Scale; NIHSS: National
Institute of Health Stroke Scale; CIs: Confidence intervals; IQR: Interquartile
range
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